busulfan has been researched along with Day Blindness in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Erer, B | 1 |
| Polchi, P | 1 |
| Lucarelli, G | 1 |
| Angelucci, E | 1 |
| Baronciani, D | 1 |
| Galimberti, M | 1 |
| Giardini, C | 1 |
| Gaziev, D | 1 |
| Maiello, A | 1 |
| Burke, E | 1 |
| Teeling, M | 1 |
| Carney, D | 1 |
| Eustace, P | 1 |
| Levine, J | 1 |
| Swanson, PD | 1 |
3 other studies available for busulfan and Day Blindness
| Article | Year |
|---|---|
CsA-associated neurotoxicity and ineffective prophylaxis with clonazepam in patients transplanted for thalassemia major: analysis of risk factors.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Anticonvulsants; beta-Thalassemia; Blood | 1996 |
The retinotoxic effects of oncological agents.
Topics: Antineoplastic Agents; Busulfan; Cisplatin; Female; Humans; Male; Retina; Tamoxifen; Vision Disorder | 1987 |
Idiopathic thrombocytosis. A treatable cause of transient ischemic attacks.
Topics: Adult; Blood Platelet Disorders; Busulfan; Female; Hemorrhage; Humans; Hyperplasia; Ischemic Attack, | 1968 |